Royalty Pharma plc
RPRX
Rangering i aksjer
#860
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Aksjekurs
$62.20
Sist synkronisert: 2026-10-21
Markedsverdi
$27.69B
Endring (1 dag)
-0.09%
Endring (1 år)
68.82%
Land
US
Handel Royalty Pharma plc (RPRX)
Kategori
Healthcare
Aksjeprishistorikk for Royalty Pharma plc (RPRX)
Høyeste sluttskurs: $58.43 den 2026-10-01
Laveste sluttskurs: $49.50 den 2020-06-01
Laveste sluttskurs: $49.50 den 2020-06-01
Aksjeprishistorikk for Royalty Pharma plc fra 2020 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | 27.24% |
| 2025 | 52.96% |
| 2024 | -9.35% |
| 2023 | -31.53% |
| 2022 | 5.51% |
| 2021 | -14.39% |
| 2020 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $45.44 | 35.30% |
SE
|
|
| $171.37 | 23.91% |
FR
|
|
| $116.39 | 58.03% |
US
|
|
| $59.52 | -0.48% |
IT
|
|
| $0.63 | -31.50% |
HK
|
